Grupo de investigacións biomédicas
GIBIOMED
Hospital de Sabadell
Barcelona, EspañaPublicacións en colaboración con investigadores/as de Hospital de Sabadell (2)
2018
-
Efficacy and safety of vandetanib for patients with advanced and progressive medullary thyroid cancer (MTC) as systemic treatment beyond first-line therapy
Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, pp. viii476
2017
-
Angiopoietin-like protein 8/betatrophin as a new determinant of type 2 diabetes remission after bariatric surgery
Translational Research, Vol. 184, pp. 35-44.e4